牛熊异动 | 中芯国际牛证涨超10%!
港股中芯国际今日高开逾2%,截至发稿,中芯国际涨2.34%,报28.45港元,中芯瑞信一十牛I涨超10%。
【通过日内融买入1手中芯国际,仅需占用本金1400港元】
公司宣布与荷兰光刻机巨头阿斯麦(ASML)签订修订后的采购协议,期限延长至今年年底。公司在公告中还披露了此前的购买金额,称根据批量采购协议,已于2020年3月16日至2021年3月2日的12个月期间,就购买用于生产晶圆的阿斯麦产品与阿斯麦集团签订购买单,总代价约为12亿美元。虽然没有明确提到“光刻机”,但“生产晶圆的阿斯麦产品”,很明显就是光刻机。另外,有业内资深人士透露,除了EUV光刻机,中芯国际几乎可以买到其他所有型号的光刻机,包括DUV(深紫外)光刻机。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.